Earlier this month an approval for Novartis's CDK inhibitor Kisqali gave it a leg up over Eli Lilly's Verzenio. Roche has a number of drugs in the market for breast cancer, but this would be its ...
CDK Global reportedly paid $25 million to cybercriminals after a mid-June ransomware attack disrupted business for thousands of car dealerships. According to a report from CNN citing multiple ...
SurvivorNet on MSN2mon
For Advanced Breast Cancer With a PIK3CA Mutation, A New Three-Drug Combination Doubles Progression-Free Survival, According to New StudyPalbociclib (brand name Ibrance) was the first CDK 4/6 inhibitor approved by the FDA to treat breast cancer. In combination, ...
CDK Global, the company behind the software ... “Ransomware is like the drug trade,” said Brett Callow, a threat analyst with the security company Emsisoft. “People will always be willing ...
As CDK Global continues making progress on bringing customers back onto its core platform after a crippling ransomware attack, cybersecurity experts told CRN that the massive disruption to car ...
Poly(ADP)ribose polymerase (PARP) inhibitors, which are drugs that exploit a cancer’s ... compared to first generation CDK inhibitors, was key to achieving a therapeutic profile to gain approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback